David B Thomas

Professor Emeritus, Epidemiology


MD University of Washington, 1963
DrPH Epidemiology, Johns Hopkins University, 1972



Research Areas

Recent Publications (PubMed)

The Addition of Systemic Terbinafine to Antifungal Combination Therapy in the Treatment of Disseminated Drug-Resistant Mold Infections in a National Cancer Institute Comprehensive Cancer Center: A Six-Year Study.
(2024 Mar)
Cureus 16(3): e55343
Thomas DB Jr, Ajayi E, Sikora A, Cozzini L, Quilitz R, Pasikhova Y, Klinkova O, Baluch A

Relationships among Non-Neoplastic Histopathological Features, Kidney Function, Proteinuria, and Other Clinical Factors in Patients Undergoing Nephrectomy.
(2023 Jan-Dec)
Glomerular Dis 3(1): 220-229
Aponte Becerra L, Salcedo Betancourt JD, Elfassy T, Iakymenko O, Thomas DB, Isaac F, Fornoni A, Zuo Y, Barisoni L, Contreras G, Munoz Mendoza J

An Event-Driven Approach to Genotype Imputation on a Custom RISC-V Cluster.
(2024 Jan-Feb)
IEEE/ACM Trans Comput Biol Bioinform 21(1): 26-35
Morris J, Rafiev A, Bragg GM, Vousden ML, Thomas DB, Yakovlev A, Brown AD

Macromolecular Crowding Is Surprisingly Unable to Deform the Structure of a Model Biomolecular Condensate.
(2023 Jan 25)
Biology (Basel) 12(2):
Shillcock JC, Thomas DB, Ipsen JH, Brown AD

JAK inhibitor blocks COVID-19 cytokine-induced JAK/STAT/APOL1 signaling in glomerular cells and podocytopathy in human kidney organoids.
(2022 Jun 8)
JCI Insight 7(11):
Nystrom SE, Li G, Datta S, Soldano KL, Silas D, Weins A, Hall G, Thomas DB, Olabisi OA

Show complete publication list

In the News

Breast self-exams: a touch of uncertainty
Honolulu Advertiser, 09/08/2008